Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €88.49 EUR
Change Today -1.47 / -1.63%
Volume 608.0
CVS On Other Exchanges
Symbol
Exchange
Mexico
Frankfurt
As of 3:42 PM 04/30/15 All times are local (Market data is delayed by at least 15 minutes).

cvs health corp (CVS) Snapshot

Open
€90.62
Previous Close
€89.96
Day High
€90.92
Day Low
€88.30
52 Week High
03/16/15 - €98.75
52 Week Low
05/5/14 - €52.64
Market Cap
99.8B
Average Volume 10 Days
1.1K
EPS TTM
--
Shares Outstanding
1.1B
EX-Date
04/22/15
P/E TM
--
Dividend
€1.46
Dividend Yield
1.19%
Current Stock Chart for CVS HEALTH CORP (CVS)

cvs health corp (CVS) Details

CVS Health Corporation, together with its subsidiaries, provides integrated pharmacy health care services in the United States. The company operates through Pharmacy Services and Retail Pharmacy segments. The Pharmacy Services segment offers pharmacy benefit management services, such as plan design and administration, formulary management, Medicare Part D services, mail order and specialty pharmacy services, retail pharmacy network management services, prescription management systems, clinical services, disease management programs, and medical pharmacy management services. This segment serves employers, insurance companies, unions, government employee groups, health plans, managed Medicaid plans and plans offered on public and private organizations, other sponsors of health benefit plans, and individuals under the CVS/caremark Pharmacy Services, Caremark, CarePlus CVS/pharmacy, RxAmerica, Accordant, SilverScript, Coram CVS/specialty, NovoLogix, and Navarro Health Services names. The Retail Pharmacy segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, personal care products, convenience foods, seasonal merchandise, and greeting cards, as well as provides photo finishing services. As of December 31, 2014, it operated 7,822 retail drugstores, 860 health care clinics, 17 onsite pharmacy stores, 27 retail specialty pharmacy stores, 11 specialty mail order pharmacies, 4 mail service dispensing pharmacies, and 86 branches, as well as 6 centers of excellence for infusion and enteral services. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014. CVS Health Corporation was founded in 1892 and is headquartered in Woonsocket, Rhode Island.

137,800 Employees
Last Reported Date: 02/10/15
Founded in 1892

cvs health corp (CVS) Top Compensated Officers

Chief Executive Officer, President, Director ...
Total Annual Compensation: $1.4M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $825.0K
Executive Vice President and President of CVS...
Total Annual Compensation: $900.0K
Executive Vice President and President of CVS...
Total Annual Compensation: $850.0K
Chief Health Care Strategy Officer, Executive...
Total Annual Compensation: $670.0K
Compensation as of Fiscal Year 2014.

cvs health corp (CVS) Key Developments

CVS Health Corporation Plans to Add New Stores

CVS Health Corporation plan to add about 150 net new stores for the full year 2015, equating to an anticipated increase in retail square footage growth of around 2%.

CVS Health Corporation Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for the Second Quarter; Revises Earnings Guidance for the Year 2015

CVS Health Corporation announced unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, net revenues were $36,332 million against $32,689 a million a year ago. Operating profit was $2,132 million against $2,024 million a year ago. Income before income tax provision was $1,998 million against $1,866 million a year ago. Net income was $1,221 million or $1.07 per diluted share against $1,129 million or $0.95 per diluted share a year ago. Net cash provided by operating activities was $1,984 million against $2,172 million a year ago. Purchases of property and equipment were $419 million against $388 million a year ago. Adjusted income before income tax provision was $2,127 million against $1,997 million a year ago. Adjusted net income was $1,294 million against $1,208 million a year ago. Adjusted earnings per share were $1.14 against $1.02 a year ago. Free cash flow $1,590 million against $1,789 million a year ago. The company generated approximately $1.8 billion of free cash. The company expects to deliver Adjusted EPS of $1.17 to $1.20 and GAAP diluted EPS from continuing operations of $1.10 to $1.13 in the second quarter of 2015. The company raised the low end of its EPS guidance range for the full year 2015. The company now expects to deliver Adjusted EPS of $5.08 to $5.19, up from $5.05 to $5.19, and GAAP diluted EPS from continuing operations of $4.80 to $4.91, up from $4.77 to $4.91 in 2015. The company also continues to expect to deliver 2015 free cash flow of $5.9 billion to $6.2 billion, and 2015 cash flow from operations of $7.6 billion to $7.9 billion. The company expects Consolidated net revenue growth to be 7% to 8.25%.

Investors Reportedly Eyes Stake In Omnicare

Omnicare Inc. (NYSE:OCR) is drawing interest from potential buyers including Express Scripts Holding Company (NasdaqGS:ESRX) and CVS Health Corporation (NYSE:CVS), people with knowledge of the matter said. Initial bids for Omnicare, which has a market value of about $8.5 billion, are due in May, the people said, asking not to be identified discussing private information. Omnicare is working with Bank of America Corp. and Centerview Partners to explore options including a possible sale, the people said. Potential bidders also include Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) and McKesson Corporation (NYSE:MCK), the people said. For any of the potential buyers, Omnicare would offer a way to boost earnings and dividends, analysts have said. Omnicare climbed 1.8% to $87.98 at the close in New York. There is no certainty Omnicare will reach a deal with any of the bidders, one of the people cautioned. Representatives for CVS, Express Scripts, McKesson and Walgreens declined to comment. A representative for Omnicare declined to comment, while spokesmen for Bank of America and Centerview didn’t immediately respond to requests for comment.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CVS:GR €88.49 EUR -1.47

CVS Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Costco Wholesale Corp $145.39 USD +2.34
Express Scripts Holding Co $86.52 USD +0.12
Home Depot Inc/The $109.55 USD +2.57
UnitedHealth Group Inc $113.20 USD +1.80
Walgreens Boots Alliance Inc $83.46 USD +0.53
View Industry Companies
 

Industry Analysis

CVS

Industry Average

Valuation CVS Industry Range
Price/Earnings 25.4x
Price/Sales 0.8x
Price/Book 3.0x
Price/Cash Flow 24.6x
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CVS HEALTH CORP, please visit www.cvshealth.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.